1Tattersfield AE, Knox A J, Britton JR, et al. Asthma [ J ].Lancet, 2002, 360:1313-1322.
2Israel E, Drazen JM, Boushey HA. The effect of polymorphisms of theβ2 adrenergic receptor on the response to regular albuterol in asthma [J]. Am J Respir Crit Care Med, 2000, 162:75 -80.
3Scott MG, Swan C, Wheatley AP, et al. Identification of novel polymorphisms within the premoter region of the human beta - 2 -adrenergic receptor gene [J]. Br J Pharmacol, 1999, 126:841 - 844.
4Drysdale CM, McGraw DW, Stack CB, et al. Complex promoter and coding region 132 - adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness [ J ]. Proc Natl Acad Sci, 2000, 97:10485 - 10488.
5Beato M, Klug J. Steroid hormone receptors: an update [J].Hum Reprod Update, 2000, 6 : 225 - 236.
6Ruiz M, Lind U, Gavfels M, et al. Characterisation of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance [J]. Clin Endocrinol, 2001, 55:363 - 371.
7Drazen JM, Silverman EK, lee TH. Heterogeneity of therapeutic responses in asthma [J]. Br Med Bull, 2000, 56:1054 -1070.
8Heise CE, O'Dowd BF, Figeuroa DJ. Characterisation of the human cysteinyl leukotriene 2 receptor [J]. J Biol Chem, 2000,275 : 30531 -30536.
9Drazen JM, Yandava CN, Dube L. Pharmacogenetic association between ALOX -5 promotor genotype and the response to anti-asthma treatment [J]. Nat Genet, 1999, 22:185-190.
10Palmer LJ. Linkages and associations to intermediate phenotypes underlying asthma and allergic disease [J]. Cure Opin Allergy Clin Immunol, 2001, 3:413-421.
